Mean Reversion
Very Weak
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Strong
Earnings
Weak
Earnings
Strong
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Neutral
Website
RUA Life Sciences Plc
Telephone
44.1294.317.073
Address
Irvine, 2 Drummond Crescent, Ayrshire, Scotland KA11 5AN
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.1 - 0.27
Trade Value (12mth)
US$8,825.00
1 week
-12.5%
1 month
15.07%
YTD
52.73%
1 year
82.61%
All time high
5.64
EPS 3 yr Growth
-97.20%
EBITDA Margin
-8.60%
Operating Cashflow
$0m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
0.00
Quick Ratio
3.90
Shares Outstanding (Fully Diluted)
62m
HALO Sector
Healthcare
Next Company Report Date
29-Jul-26
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 12 May 26 | |
| 18 March 26 | |
| 17 March 26 | |
| 13 February 26 | |
| 30 January 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.05 | N/A | N/A | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.05 | N/A | N/A | | | | ||
Growth | % | | | | | 50.4 | N/A | N/A | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
